Long-Term Humoral and Cellular Immune Responses Elicited by a Heterologous Plasmodium vivax Apical Membrane Antigen 1 Protein Prime/Adenovirus Boost Immunization Protocol
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long-Term Humoral and Cellular Immune Responses Elicited by a Heterologous Plasmodium vivax Apical Membrane Antigen 1 Protein Prime/Adenovirus Boost Immunization Protocol
Authors
Keywords
-
Journal
INFECTION AND IMMUNITY
Volume 79, Issue 9, Pages 3642-3652
Publisher
American Society for Microbiology
Online
2011-07-06
DOI
10.1128/iai.05048-11
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase I Safety and Immunogenicity Trial of Plasmodium vivax CS Derived Long Synthetic Peptides Adjuvanted with Montanide ISA 720 or Montanide ISA 51
- (2011) Sócrates Herrera et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Preclinical Vaccine Study of Plasmodium vivax Circumsporozoite Protein Derived-Synthetic Polypeptides Formulated in Montanide ISA 720 and Montanide ISA 51 Adjuvants
- (2011) Myriam Arévalo-Herrera et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Antibody-Mediated and Cellular Immune Responses Induced in Naive Volunteers by Vaccination with Long Synthetic Peptides Derived from the Plasmodium vivax Circumsporozoite Protein
- (2011) Myriam Arévalo-Herrera et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- CD8+T-cell Activation in Mice Injected with a Plasmid DNA Vaccine Encoding AMA-1 of the Reemerging KoreanPlasmodium vivax
- (2011) Hyo-Jin Kim et al. KOREAN JOURNAL OF PARASITOLOGY
- Pre-Existing Adenovirus Immunity Modifies a Complex Mixed Th1 and Th2 Cytokine Response to an Ad5/HIV-1 Vaccine Candidate in Humans
- (2011) Samuel O. Pine et al. PLoS One
- Adenovirus type-35 vectors block human CD4+ T-cell activation via CD46 ligation
- (2011) W. C. Adams et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Th1 Immune Response to Plasmodium falciparum Circumsporozoite Protein Is Boosted by Adenovirus Vectors 35 and 26 with a Homologous Insert
- (2010) K. Radosevic et al. Clinical and Vaccine Immunology
- Enhancing Blood-Stage Malaria Subunit Vaccine Immunogenicity in Rhesus Macaques by Combining Adenovirus, Poxvirus, and Protein-in-Adjuvant Vaccines
- (2010) S. J. Draper et al. JOURNAL OF IMMUNOLOGY
- Identification and localization of minimal MHC-restricted CD8+ T cell epitopes within the Plasmodium falciparum AMA1 protein
- (2010) Martha Sedegah et al. MALARIA JOURNAL
- Adenovectors induce functional antibodies capable of potent inhibition of blood stage malaria parasite growth
- (2010) Joseph T. Bruder et al. VACCINE
- Phase 1 safety and immunogenicity trial of the Plasmodium falciparum blood-stage malaria vaccine AMA1-C1/ISA 720 in Australian adults
- (2010) Mark A. Pierce et al. VACCINE
- Heterologous HIV-based lentiviral/adenoviral vectors immunizations result in enhanced HIV-specific immunity
- (2010) Benyam Asefa et al. VACCINE
- A recombinant vaccine based on domain II of Plasmodium vivax Apical Membrane Antigen 1 induces high antibody titres in mice
- (2010) Fernanda Gentil et al. VACCINE
- High Antibody Titer against Apical Membrane Antigen-1 Is Required to Protect against Malaria in the Aotus Model
- (2009) Sheetij Dutta et al. PLoS One
- Determinants of In Vitro Drug Susceptibility Testing of Plasmodium vivax
- (2008) B. Russell et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
- (2008) Susan P Buchbinder et al. LANCET
- Chloroquine-resistant Plasmodium vivax malaria in Debre Zeit, Ethiopia
- (2008) Hiwot Teka et al. MALARIA JOURNAL
- A Trial of Combination Antimalarial Therapies in Children from Papua New Guinea
- (2008) Harin A. Karunajeewa et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Immunogenicity of a Malaria Vaccine, Plasmodium falciparum AMA-1/MSP-1 Chimeric Protein Formulated in Montanide ISA 720 in Healthy Adults
- (2008) Jinhong Hu et al. PLoS One
- Safety and Immunogenicity of a Recombinant Plasmodium falciparum AMA1 Malaria Vaccine Adjuvanted with Alhydrogel™, Montanide ISA 720 or AS02
- (2008) Meta Roestenberg et al. PLoS One
- Apical membrane antigen 1: a malaria vaccine candidate in review
- (2008) Edmond J. Remarque et al. TRENDS IN PARASITOLOGY
- A Phase 1 trial of PfCP2.9: An AMA1/MSP1 chimeric recombinant protein vaccine for Plasmodium falciparum malaria
- (2008) Elissa Malkin et al. VACCINE
- Epitope mapping and protective immunity elicited by adenovirus expressing the Leishmania amastigote specific A2 antigen: Correlation with IFN-γ and cytolytic activity by CD8+ T cells
- (2008) Daniela M. Resende et al. VACCINE
- Antibody responses to a panel of Plasmodium falciparum malaria blood-stage antigens in relation to clinical disease outcome in Sudan
- (2008) Nnaemeka C. Iriemenam et al. VACCINE
- Multidrug-Resistant Plasmodium vivax Associated with Severe and Fatal Malaria: A Prospective Study in Papua, Indonesia
- (2008) Emiliana Tjitra et al. PLOS MEDICINE
- Plasmodium vivax and Mixed Infections Are Associated with Severe Malaria in Children: A Prospective Cohort Study from Papua New Guinea
- (2008) Blaise Genton et al. PLOS MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now